Learning from previous responses in phase I dose-escalation studies
Continuing Medical Education in Clinical Pharmacology and Therapeutics: report of a questionnaire survey
Seasonal differences in finger skin temperature and microvascular blood flow in healthy men and women are exaggerated in women with primary Raynaud's phenomenon
Pharmacokinetic–pharmacodynamic model for perindoprilat regional haemodynamic effects in healthy volunteers and in congestive heart failure patients
Contribution of dihydrocodeine and dihydromorphine to analgesia following dihydrocodeine administration in man: a PK–PD modelling analysis
Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data
In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine 1-carboxamide)
Diurnal variation in the biliary excretion of flomoxef in patients with percutaneous transhepatic biliary drainage
Influence of [beta]-adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5-HT1B/1D agonist: differential effects of propranolol, nadolol and metoprolol
Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies
Nature, frequency and determinants of prescription modifications in Dutch community pharmacies
Dose–response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate
Effect of the CYP2C19 oxidation polymorphism on fluoxetine metabolism in Chinese healthy subjects
Influence of the CYP2D6*10 allele on the metabolism of mexiletine by human liver microsomes
Dictionary of pharmacoepidemiology
Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential—towards a consensus
COST B15: modelling in drug development